Lombard Odier Asset Management (Switzerland)’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.63M | Hold |
4,219
| – | – | 0.05% | 253 |
|
|
2026
Q1 | $1.24M | Buy |
+4,219
| New | +$1.39M | 0.05% | 266 |
|
|
2025
Q4 | – | Sell |
-16,594
| Closed | -$5.36M | – | 290 |
|
|
2025
Q3 | $5.36M | Buy |
16,594
+2,432
| +17% | +$756K | 0.24% | 95 |
|
|
2025
Q2 | $5.51M | Buy |
14,162
+1,768
| +14% | +$711K | 0.28% | 84 |
|
|
2025
Q1 | $5.39M | Buy |
+12,394
| New | +$4.98M | 0.31% | 76 |
|
|
2023
Q2 | – | Sell |
-2,565
| Closed | -$1.18M | – | 220 |
|
|
2023
Q1 | $1.18M | Buy |
2,565
+298
| +13% | +$142K | 0.1% | 168 |
|
|
2022
Q4 | $1.16M | Buy |
2,267
+174
| +8% | +$88.3K | 0.09% | 169 |
|
|
2022
Q3 | $951K | Sell |
2,093
-178
| -8% | -$85.2K | 0.08% | 158 |
|
|
2022
Q2 | $1.1M | Buy |
+2,271
| New | +$1.12M | 0.09% | 146 |
|
|
2022
Q1 | – | Sell |
-2,784
| Closed | -$1.29M | – | 237 |
|
|
2021
Q4 | $1.29M | Buy |
+2,784
| New | +$1.17M | 0.08% | 121 |
|
|
2021
Q3 | – | Sell |
-3,797
| Closed | -$1.45M | – | 304 |
|
|
2021
Q2 | $1.45M | Sell |
3,797
-28
| -0.7% | -$10.7K | 0.07% | 160 |
|
|
2021
Q1 | $1.37M | Buy |
+3,825
| New | +$1.23M | 0.09% | 128 |
|
|
2020
Q4 | – | Sell |
-3,603
| Closed | -$968K | – | 203 |
|
|
2020
Q3 | $968K | Buy |
+3,603
| New | +$969K | 0.1% | 148 |
|
|
2020
Q2 | – | Sell |
-1,936
| Closed | -$440K | – | 209 |
|
|
2020
Q1 | $440K | Sell |
1,936
-1,776
| -48% | -$484K | 0.06% | 219 |
|
|
2019
Q4 | $1.12M | Sell |
3,712
-44,839
| -92% | -$12.3M | 0.11% | 167 |
|
|
2019
Q3 | $11.7M | Sell |
48,551
-8,895
| -15% | -$2.44M | 1.26% | 26 |
|
|
2019
Q2 | $16.2M | Sell |
57,446
-13,121
| -19% | -$3.58M | 1.65% | 17 |
|
|
2019
Q1 | $20.3M | Sell |
70,567
-12,728
| -15% | -$3.68M | 2.05% | 9 |
|
|
2018
Q4 | $21.9M | Sell |
83,295
-14,805
| -15% | -$4.07M | 2.48% | 5 |
|
|
2018
Q3 | $26.9M | Sell |
98,100
-16,059
| -14% | -$4.17M | 2.66% | 4 |
|
|
2018
Q2 | $27.2M | Buy |
114,159
+18,431
| +19% | +$4.27M | 2.86% | 5 |
|
|
2018
Q1 | $21M | Buy |
95,728
+792
| +0.8% | +$186K | 2.18% | 6 |
|
|
2017
Q4 | $21.4M | Buy |
94,936
+76,553
| +416% | +$16.3M | 2.07% | 9 |
|
|
2017
Q3 | $3.49M | Sell |
18,383
-28,342
| -61% | -$5.39M | 0.34% | 61 |
|
|
2017
Q2 | $8.79M | Buy |
46,725
+11,725
| +34% | +$2.11M | 1.01% | 25 |
|
|
2017
Q1 | $5.79M | Buy |
+35,000
| New | +$5.57M | 0.64% | 39 |
|
|
2016
Q2 | – | Sell |
-13,318
| Closed | -$1.85M | – | 334 |
|
|
2016
Q1 | $1.85M | Buy |
13,318
+5,258
| +65% | +$703K | 0.22% | 81 |
|
|
2015
Q4 | $1.12M | Buy |
8,060
+3,082
| +62% | +$425K | 0.14% | 98 |
|
|
2015
Q3 | $697K | Sell |
4,978
-3,370
| -40% | -$506K | 0.06% | 134 |
|
|
2015
Q2 | $1.37M | Buy |
8,348
+2,361
| +39% | +$377K | 0.1% | 92 |
|
|
2015
Q1 | $930K | Buy |
5,987
+1,587
| +36% | +$226K | 0.1% | 162 |
|
|
2014
Q4 | $556K | Sell |
4,400
-26,414
| -86% | -$3.26M | 0.06% | 211 |
|
|
2014
Q3 | $3.7M | Buy |
30,814
+25,233
| +452% | +$2.89M | 0.1% | 228 |
|
|
2014
Q2 | $598K | Buy |
+5,581
| New | +$575K | 0.07% | 190 |
|
Other funds holding ELV
Lombard Odier Asset Management (Switzerland)'s ELV Position: Q2 2026 in Review
Lombard Odier Asset Management (Switzerland) held its Elevance Health (ELV) position steady in Q2 2026 at 4,219 shares worth $1.63M. The position accounts for 0.05% of the portfolio, ranked #253.
Lombard Odier Asset Management (Switzerland) first reported a position in ELV in Q2 2014 and has held it in 34 quarters since. The position peaked at $27.2M in Q2 2018. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Lombard Odier Asset Management (Switzerland) held 4,219 shares of Elevance Health worth $1.63M as of Q2 2026.
- Lombard Odier Asset Management (Switzerland) left its Elevance Health share count unchanged in Q2 2026.
- Elevance Health made up 0.05% of Lombard Odier Asset Management (Switzerland)'s portfolio in Q2 2026, its #253 holding.
- Lombard Odier Asset Management (Switzerland) first reported a position in Elevance Health in Q2 2014 and has held it in 34 quarters since.
- Lombard Odier Asset Management (Switzerland)'s Elevance Health position peaked at $27.2M in Q2 2018.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2026, filed 14 Aug 2026.